Related Experiment Videos
The SOCS-1 story
1The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia.
Abstract:
SOCS-1 is an intracellular protein able to block the differentiation of leukemic M1 cells inducible by interferon gamma (IFN-gamma) or regulators using the gp130 receptor. Its transient production is readily inducible by cytokine stimulation, and SOCS-1 appears to be a negative feedback molecule, modulating or suppressing receptor signaling activated by at least eight cytokines. Mice lacking SOCS-1 develop a lethal neonatal syndrome including liver damage, depletion of T and B lymphocytes, and granulocyte-macrophage infiltration of the liver, lungs, pancreas, heart, and skin. These and the associated hematologic abnormalities in SOCS-1-/- mice can all be mimicked by the neonatal injection of high doses of IFN-gamma. The lethal neonatal disease in SOCS-1-/- mice is preventable by injection of antibodies to IFN-gamma or by crossing SOCS-1-/- mice with IFN-gamma-/- mice, identifying IFN-gamma as being essential for the initiation of the neonatal disease and death. IFN-gamma appears not to be overproduced in SOCS-1-/- mice, and the lethal disease may arise from hyperresponsiveness of -/- cells to normal levels of IFN-gamma. SOCS-1-/- mice allowed to survive the neonatal period by cross-mating with IFN-gamma-/- mice may well ultimately develop other disease states, because loss of SOCS-1 potentially renders them hyperresponsive to other cytokine signaling.
Insights
Suppressor of Cytokine Signaling 1 (SOCS-1) is vital for preventing lethal neonatal disease in mice. Loss of SOCS-1 leads to hyperresponsiveness to interferon gamma (IFN-gamma), causing severe health issues.
Area of Science:
- Immunology
- Molecular Biology
- Genetics
Background:
- SOCS-1 is an intracellular protein that inhibits cytokine signaling pathways, including those mediated by interferon gamma (IFN-gamma).
- It acts as a negative feedback regulator for signaling initiated by at least eight distinct cytokines via receptors like gp130.
- SOCS-1 production is transient and inducible upon cytokine stimulation.
Discussion:
- Mice lacking functional SOCS-1 (SOCS-1-/-) exhibit a lethal neonatal syndrome characterized by liver damage and immune cell infiltration.
- This syndrome closely resembles the effects of high-dose neonatal IFN-gamma injection.
- The disease is preventable by anti-IFN-gamma antibodies or by removing the IFN-gamma gene, confirming IFN-gamma's critical role.
Key Insights:
- The absence of SOCS-1 does not cause IFN-gamma overproduction but rather a hyperresponsiveness of cells to normal IFN-gamma levels.
- IFN-gamma is essential for initiating the lethal neonatal disease and mortality in SOCS-1 deficient mice.
- SOCS-1 plays a crucial role in maintaining immune homeostasis by preventing excessive cytokine signaling.
Outlook:
- Further research is needed to understand the long-term consequences for SOCS-1-/- mice that survive the neonatal period.
- Loss of SOCS-1 may predispose individuals to other cytokine-mediated diseases due to heightened sensitivity to various signaling pathways.
- Investigating SOCS-1's role in other immune-related disorders could reveal therapeutic targets.